Is It Time to Give Up on FitBit’s Stock?

A loyal fanbase may not be enough to save this underdog.

| More on:
Man considering whether to sell or buy

Image source: Getty Images.

Fitbit (NYSE: FIT) is facing serious issues. The latest chapter in this drama is that due to its new Versa Lite fitness smartwatch collecting dust on retail store shelves, the company has made a $150 million reduction in 2019 expected full-year revenue. The stock seems like a bargain, priced at less than two times its cash and investible assets, but it’s cheap for good reason. The core device business is suffering and efforts to pivot haven’t gained traction.

Let’s look at where this fitness tracking device manufacturer is today and whether investors can bet on this underdog to beat the odds.

Pricing power and margins have degraded

Investors love companies with pricing power like Walt Disney that can raise prices every year at its theme parks but still draw record crowds. Fitbit, on the other hand, seems to have lost that ability (if it ever had it at all). Stuck between low-priced competitors like Huami and the popular premium-priced Apple watch, CEO James Park says that it can succeed with products “in the $50 to $300 price range that are easy to use and feature-rich.” But the track record of its average sales prices (ASP) shows its customers are less willing to pay up for its higher-priced products. In Q1 2018, ASPs peaked with the introduction of its first smartwatch, but have degraded to $86 in the most recent quarter and may not ever recover back to its highs.

Metric Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019
Smartwatch % of revenue 30% 56% 49% 43% 43% 39%
Average selling price $112 $106 $108 $100 $91 $86
Gross margin 46% 39.8% 39% 38% 32.9% 34.5%

Source: Fitbit earnings announcements, table by author.

Gross margins have also suffered from the expansion into smartwatches. This was not unexpected, but the low 30% gross margins in the first half of 2019 are a far cry from the tracker-only gross margins like the 47.8% the company posted as recently as Q3 2016. This margin compression leaves less money for marketing and research and development, which have put hobbled the company’s cash flow and profits.

With the tracker business struggling, investors may be pinning hopes on alternative revenue streams.

Revenue beyond the device is still small

At the end of 2016, I wrote about Fitbit’s efforts to bring in non-device revenue including its personal training app, corporate wellness programs, and its digital health initiatives. Over two years later, those efforts (now called Fitbit Health Solutions) are still only a small part of the company.

This business is on track to achieve revenues of $100 million in 2019, growing 24% from last year. This number sounds impressive but accounts for less than 7% of the midpoint in full-year revenue guidance. But wait, there’s more to this nine-figure revenue number that investors should understand. On the most recent earnings call, Chief Financial Officer Ron Kisling explained that “Fitbit Health Solutions’ revenue remains skewed toward hardware.” Like it or not, Fitbit is still predominantly a hardware company, mainly due to opportunities it’s missed to pivot.

Too little to show for too many opportunities

There were 29.2 million devices sold in 2017 and 2018, but the number of active users only increased by 4.4 million over that period. It’s pretty disappointing that only 15% of devices sold have resulted in new active users. It’s even more disheartening to note that the active user metric is a really low bar. Customers only have to log 100 steps in the previous 90 days to be counted as “active”. It’s tough to grow a brand when its products aren’t being used. Creating more engaged users is probably Fitbit’s biggest missed opportunity.

Two years ago, the company was selected by the U.S. Food and Drug Administration (FDA) as one of only nine companies to participate in its Digital Health Software Precertification Pilot Program. This program was intended to drive software as a medical device innovation and streamline the path for approvals. CEO James Park said recently that “we’re continuing to work with the FDA on a variety of initiatives, including around sleep apnea. I just can’t give you a time frame right now.” No tangible results makes this big missed opportunity number two.

Management’s latest idea is bundling its new premium software offering with its devices for the upcoming holiday season. Park even suggested giving “away certain hardware devices for free and then having a recurring revenue stream on the services side with that user for a longer period of time.” This might work, but I wouldn’t blame investors who are saying “show me the money!”

Will Fitbit survive?

Fitbit is facing a wall of challenges and management may realize they can’t succeed without help. Reports indicate that this tracker-manufacturer is considering options with potential acquirers. The company is certainly not dead yet. With plenty of cash and a loyal following, it is likely doomed to the fate of other consumer-facing tech companies: the king of a small niche market. Even with a longshot chance of a buyout-stock-pop, investors would do well to put their money elsewhere.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Brian Withers owns shares of Apple and Walt Disney. The Motley Fool owns shares of and recommends Apple, Fitbit, and Walt Disney. The Motley Fool has the following options: long January 2021 $60 calls on Walt Disney, short October 2019 $125 calls on Walt Disney, short January 2020 $155 calls on Apple, long January 2020 $150 calls on Apple, short January 2020 $155 calls on Apple, and long January 2020 $150 calls on Apple. The Motley Fool has a disclosure policy.

More on Tech Stocks

man sitting in front of 3 screens programming
Tech Stocks

2 Growth Stocks to Hold for the Next 10 Years

Are you interested in growth stocks? Here are two picks to hold for the next 10 years!

Read more »

investment research
Tech Stocks

2 Hot Stocks to Buy and Hold Until You Retire

Are you looking for stocks to buy and hold until you retire? Here are two top picks!

Read more »

tsx today
Tech Stocks

TSX Today: What to Watch for in Stocks on Wednesday, September 27

An overnight bullish movement in oil and gas prices could lift TSX energy stocks at the open today.

Read more »

Dots over the earth connecting the world
Tech Stocks

1 Magnificent TSX Stock That Turned $10,000 Into $163,000

Constellation Software has crushed the broader markets in the past decade. Here's why I remain bullish on the TSX tech…

Read more »

Question marks in a pile
Tech Stocks

Up 57% in 2023, Is BlackBerry Stock Still a Buy?

Here are some key reasons I don’t find BB stock overvalued, despite its solid 57% year-to-date gains.

Read more »

crypto, chart, stocks
Tech Stocks

CGI Stock: Outperforming Among Falling Tech Stocks

CGI stock (TSX:GIB.A) has blasted past 52-week highs, on top of long-term growth that's remained stable throughout the decades.

Read more »

grow money, wealth build
Tech Stocks

How to Turn Your TFSA Into a Gold Mine Starting With $6,500

These two growth stocks can help super-charge your TFSA savings.

Read more »

man sitting in front of 3 screens programming
Tech Stocks

Shopify Stock or Microsoft Shares: Better Buy for the AI Revolution?

Shopify (TSX:SHOP) and Microsoft (NASDAQ:MSFT) are two of the most impressive growth stocks to watch, as tech slips further from…

Read more »